TTHX1114 intracameral injection / Trefoil Therapeutics  >>  Phase 2
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
TTHX1114 intracameral injection / Trefoil Therapeutics
NCT04676737: TTHX1114(NM141) in Combination With DWEK/DSO

Completed
2
49
US
TTHX1114(NM141)
Trefoil Therapeutics, Inc.
Fuchs' Endothelial Dystrophy, Fuchs Dystrophy, Fuchs
11/22
01/23
OPTIC, NCT04812067: A Safety and Efficacy Trial of TTHX1114 in People With CED

Completed
2
41
US
TTHX1114
Trefoil Therapeutics, Inc.
Corneal Endothelial Dystrophy
08/23
10/23
INTREPID, NCT04520321: A Phase 1/ Phase 2 Study of TTHX1114(NM141)

Completed
1/2
22
US
TTHX1114(NM141), Vehicle (placebo)
Trefoil Therapeutics, Inc.
Corneal Endothelial Dystrophy, Fuchs Endothelial Corneal Dystrophy, Pseudophakic Bullous Keratopathy, Endothelial Dysfunction
04/21
05/21

Download Options